ClinConnect ClinConnect Logo
Search / Trial NCT04972526

Resuscitative TEE Collaborative Registry

Launched by UNIVERSITY OF PENNSYLVANIA · Jul 19, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Transesophageal Echocardiography Resuscitation Cardiac Arrest Point Of Care Ultrasound Focused Cardiac Ultrasound

ClinConnect Summary

The Resuscitative TEE Collaborative Registry is a clinical trial aimed at understanding how a specific heart imaging test called transesophageal echocardiography (TEE) can help critically-ill patients, particularly those experiencing cardiac arrest or shock. This study is focused on patients over the age of 18 who are in emergency or intensive care settings and receive this heart imaging as part of their regular medical care. The researchers want to find out how safe this procedure is and how it affects patient care and outcomes.

If you or a loved one is a critically-ill adult and might receive focused TEE during treatment, you may be eligible to participate in this study. Participants can expect to have their heart images taken while they are receiving care, and the researchers will track various details like how often the test is used, the reasons for its use, and any complications that may arise. It's important to note that children and certain vulnerable populations are not included in this trial, as the focus is solely on adult patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting.
  • Exclusion Criteria:
  • Children (age under 18 years)
  • Vulnerable populations

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Felipe Teran, MD, MSCE

Study Chair

Weill Medical College of Cornell University

Benjamin Abella, MD, MPhil

Study Director

University of Pennsylvania

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials